Journal: Brain Communications
Article Title: Is there an immunological cross-reactivity of antibodies to the myelin oligodendrocyte glycoprotein and coronaviruses?
doi: 10.1093/braincomms/fcae106
Figure Lengend Snippet: Antibody reactivity against SARS-CoV-2 and common coronaviruses in samples from people with SARS-CoV-2 infection (COVID-19), SARS-CoV-2 vaccination or negative/naïve for SARS-CoV-2, as measured by ProcartaPlex assay . Total immunoglobulin (Ig) antibodies against ( A ) SARS-CoV-2 N ( P < 0.001, ε 2 = 0.697), ( B ) RBD ( P < 0.001, ε 2 = 0.725), ( C ) S(trimer) ( P < 0.001, ε 2 = 0.732) and ( D ) S1 proteins ( P < 0.001 ε 2 = 0.737); and ( E ) CoV-229E ( P = 0.007 ε 2 = 0.128), ( F ) CoV-HKU1 ( P = 0.008, ε 2 = 0.126), ( G ) CoV-OC43 ( P = 0.330 ε 2 = 0.049) and ( H ) CoV-NL63 ( P = 0.090, ε 2 = 0.079) were measured using the Coronavirus Ig Total Human 11-Plex ProcartaPlex™ Panel (Invitrogen, EPX110-16000-901). Significance of group differences was tested using the Kruskal-Wallis test and effect sizes ε 2 and P -values are indicated above. Only group differences (analysed Dunn’s multiple comparison test) within each subgroup (SARS-CoV-2 infection, SARS-CoV-2 vaccination or negative/naïve) are shown, asterisks indicate a significant difference between groups after correction for multiple comparisons (21) using the two-stage linear step-up procedure of Benjamini, Krieger and Yekutieli. Data are shown as boxplots (boxes represent 25th to 75th percentiles with medians indicated by the horizontal lines, whiskers represent minimum to maximum) with individual data points (circles). CNS, other demyelinating disease; CoV, coronavirus; Ig, total immunoglobulin; IgA, immunoglobulin A; IgG, immunoglobulin G; IgM, immunoglobulin M; MOG, myelin oligodendrocyte glycoprotein; MOGAD, MOG antibody-associated demyelinating disease; N, SARS-CoV-2 nucleocapsid protein; noCNS, no neurological symptoms; RBD, receptor binding domain; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; S, SARS-CoV-2 spike protein; S1, S1 subunit SARS-CoV-2 spike protein; S(trimer), trimer of SARS-CoV-2 spike protein; U/ml, U/ml.
Article Snippet: Additionally, antibody analysis of selected sera and/or purified IgG fractions were performed against the following antigens: SARS-CoV-2-N (Invitrogen RP87665), CoV-229E (HCoV-229E NP, Sino Biologicals 40640), CoV-OC43 (HCoV-OC43 NP, Sino Biologicals 40643), CoV-HKU1 (HCoV-HKU1 NP, Sino Biologicals 40642) and overlapping 20mer peptides of SARS-CoV-2 N 1-242 (synthetized by Genscript, Uniprot P0DTC9).
Techniques: Infection, Comparison, Binding Assay